Detalhe da pesquisa
1.
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.
Oncologist
; 28(2): 139-148, 2023 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36367377
2.
An Analysis of Patients with DNA Repair Pathway Mutations Treated with a PARP Inhibitor.
Oncologist
; 25(1): e60-e67, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31391296
3.
Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors.
Invest New Drugs
; 36(1): 85-95, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28726132
4.
Clinical study of genomic drivers in pancreatic ductal adenocarcinoma.
Br J Cancer
; 117(4): 572-582, 2017 Aug 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28720843
5.
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
Lancet
; 387(10018): 545-557, 2016 Feb 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26615328
6.
Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors.
Oncology
; 91(5): 251-260, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27598338
7.
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer.
Breast Cancer Res Treat
; 147(3): 579-88, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25209003
8.
Determinants of patient screen failures in Phase 1 clinical trials.
Invest New Drugs
; 31(3): 774-9, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23135779
9.
Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials.
Invest New Drugs
; 31(4): 1056-65, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23242862
10.
Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies.
Invest New Drugs
; 30(6): 2334-43, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-22160853
11.
Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Based Chemotherapy and Olaparib.
Biomedicines
; 10(11)2022 Oct 26.
Artigo
Inglês
| MEDLINE | ID: mdl-36359225
12.
Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
Genome Med
; 12(1): 80, 2020 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-32988401
13.
Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer: A Phase 1b/2 Pilot Clinical Trial.
JAMA Oncol
; 6(1): 125-132, 2020 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31580386
14.
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma.
Oncotarget
; 11(21): 1929-1941, 2020 May 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32523648
15.
Blackberry-induced hand-foot skin reaction to sunitinib.
Invest New Drugs
; 27(4): 389-90, 2009 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-18998055
16.
A prospective, randomized clinical trial to assess the cost-effectiveness of a modern foam dressing versus a traditional saline gauze dressing in the treatment of stage II pressure ulcers.
Ostomy Wound Manage
; 55(2): 50-5, 2009 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19246785
17.
Skeletal metastases in pancreatic cancer: a retrospective study and review of the literature.
Yale J Biol Med
; 82(1): 1-6, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-19325940
18.
Treatment According to a Comprehensive Molecular Profiling Can Lead to a Better Outcome in Heavily Pretreated Patients With Metastatic Cancer: Data of a Pooled Analysis.
Cancer J
; 25(2): 73-79, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30896526
19.
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial.
Eur J Cancer
; 105: 71-78, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30414528
20.
Camp Raising Spirits: An Oncology Nursing Society Chapter Leadership Success Storyâ©.
Clin J Oncol Nurs
; 21(4): 506-508, 2017 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28738045